Teresa Gilewski - Concepedia

Author

Teresa Gilewski

Memorial Sloan Kettering Cancer Center

Also Known As

T A Gilewski, T Gilewski, T. A. Gilewski, T. Gilewski, TERESA GILEWSKI, Teresa A. Gilewski, Teresa Gilewski

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center University of Chicago Cornell University Centre international de recherche sur le cancer

About

Teresa Gilewski is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	1.4K
2	Public Health	2	2	103
3	Social Sciences	2	2	111
4	Allergy	2	2	408
5	Health Sciences	1	1	29

Teresa Gilewski

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Weekly Trastuzumab and Paclitaxel Therapy for Metastatic Breast Cancer With Analysis of Efficacy by <i>HER2</i> Immunophenotype and Gene Amplification Andrew D. Seidman, Monica Fornier, Francisco J. Esteva, Journal of Clinical Oncology	2001	548
Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer Susan L. Neuhausen, Teresa Gilewski, Larry Norton, Nature Genetics Breast OncologySomatic VariantGeneticsCancer GenomicsBreast Cancer	1996	308
Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer. Bonnie Reichman, Andrew D. Seidman, John Crown, Journal of Clinical Oncology	1993	239
Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer. Andrew D. Seidman, Amy Tiersten, Clifford A. Hudis, Journal of Clinical Oncology	1995	204
Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: A phase I trial Teresa Gilewski, Govindaswami Ragupathi, Sonal Bhuta, Proceedings of the National Academy of Sciences Breast OncologyAllergyMedicineImmunologyGlobo H	2001	204
Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21. Teresa Gilewski, Sucharita Adluri, Govind Ragupathi, PubMed VaccinationMuc1 PeptideTumor ImmunologyImmunocytochemical TechniqueAllergy	2000	204
Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer. C. Hudis, Andrew D. Seidman, John Crown, Journal of Clinical Oncology	1996	152
Germline BRCA1 185delAG mutations in Jewish women with breast cancer Kenneth Offit, Patricia McGuire, Alice E. Schluger, The Lancet Breast OncologyOncologyMedicineGeneticsPathology	1996	151
A Phase II Trial of Erlotinib in Combination with Bevacizumab in Patients with Metastatic Breast Cancer Maura N. Dickler, Hope S. Rugo, Carey A. Eberle, Clinical Cancer Research	2008	119
Sequential Dose-Dense Doxorubicin, Paclitaxel, and Cyclophosphamide for Resectable High-Risk Breast Cancer: Feasibility and Efficacy Clifford A. Hudis, Andrew D. Seidman, José Baselga, Journal of Clinical Oncology	1999	116

Page 1